Antibacterial activity of human defensins on anaerobic intestinal bacterial species: a major role of HBD-3

Microbes and Infection

Volumn 11, Issue 3, 2009, Pages 384-393

  Nuding, Sabine ^a   Zabel, Lutz T ^b   Enders, Corinne ^c   Porter, Edith ^d   Fellermann, Klaus ^e   Wehkamp, Jan ^a   Mueller, Holger A G ^b   Stange, Eduard F ^e  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b KLINIK AM EICHERT   (Germany)

^c California State University ^*

^d CALIFORNIA STATE UNIVERSITY   (United States)

^e ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

Anaerobic bacteria; Antimicrobials; Defensins; Gut

Indexed keywords

BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; DEFENSIN; HUMAN DEFENSIN 5; UNCLASSIFIED DRUG;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATION; BACTEROIDES; BACTEROIDES FRAGILIS; BACTEROIDES OVATUS; BACTEROIDES THETAIOTAOMICRON; BACTEROIDES VULGATUS; BIFIDOBACTERIUM LONGUM; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; INTESTINE FLORA; LACTOBACILLUS JOHNSONII; LACTOBACILLUS LONGUM; MEMBRANE POTENTIAL; NONHUMAN; PANETH CELL; PARABACTEROIDES DISTASONIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BACTERIA (MICROORGANISMS); BACTEROIDES; BACTEROIDES FRAGILIS; BACTEROIDES SP.;

EID: 62649119114     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2009.01.001     Document Type: Article

References (35)

1. Sears C.L. A dynamic partnership: celebrating our gut flora. Anaerobe 11 (2005) 247-251
2. Ott S.J., Musfeldt M., Wenderoth D.F., Hampe J., Brant O., Folsch U.R., Timmis K.N., and Schreiber S. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53 (2004) 685-693
3. Turner J.R. Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am. J. Pathol 169 (2006) 1901-1909
4. Sartor R.B. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol 3 (2006) 390-407
5. Manichanh C., Rigottier-Gois L., Bonnaud E., Gloux K., Pelletier E., Frangeul L., Nalin R., Jarrin C., Chardon P., Marteau P., Roca J., and Dore J. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55 (2006) 205-211
6. Kleessen B., Kroesen A.J., Buhr H.J., and Blaut M. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls, Scand. J. Gastroenterol 37 (2002) 1034-1041
7. Howell S.J., Wilk D., Yadav S.P., and Bevins C.L. Antimicrobial polypeptides of the human colonic epithelium. Peptides 24 (2003) 1763-1770
8. Tollin M., Bergman P., Svenberg T., Jornvall H., Gudmundsson G.H., and Agerberth B. Antimicrobial peptides in the first line defence of human colon mucosa. Peptides 24 (2003) 523-530
9. Cash H.L., Whitham C.V., Behrendt C.L., and Hooper L.V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 25 313 (2006) 1126-1130
10. Sahl H.G., Pag U., Bonness S., Wagner S., Antcheva N., and Tossi A. Mammalian defensins: structures and mechanism of antibiotic activity. J. Leukoc. Biol 77 4 (2005) 466-475
11. Hale J.D., and Hancock R.E. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria, Expert Rev. Anti. Infect. Ther 5 (2007) 951-959
12. Wehkamp J., Harder J., Weichenthal M., Mueller O., Herrlinger K.R., Fellermann K., Schroeder J.M., and Stange E.F. Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm. Bowel Dis 9 (2003) 215-223
13. Schauber J., Rieger D., Weiler F., Wehkamp J., Eck M., Fellermann K., Scheppach W., Gallo R., and Stange E.F.S. Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases. Eur. J. Gastroenterol. Hepatol 18 (2006) 615-621
14. Harder J., Bartels J., Christophers E., and Schroder J.M. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem 276 (2001) 5707-5713
15. Nuding S., Fellermann K., Wehkamp J., Mueller H.A., and Stange E.F. A flow cytometric assay to monitor antimicrobial activity of defensins and cationic tissue extracts. J. Microbiol. Methods 65 (2006) 335-345
16. Porter E.M., van Dam E., Valore E.V., and Ganz T. Broad-spectrum antimicrobial activity of human intestinal defensin 5. Infect. Immun 65 (1997) 2396-2401
17. Joly S., Maze C., McCray Jr. P.B., and Guthmiller J.M. Human {beta}-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J. Clin. Microbiol 42 (2004) 1024-1029
18. Shelburne C.E., Coulter W.A., Olguin D., Lantz M.S., and Lopatin D.E. Induction of {beta}-defensin resistance in the oral anaerobe Porphyromonas gingivalis, Antimicrob. Agents Chemother 49 (2005) 183-187
19. Nuding S., Fellermann K., Wehkamp J., and Stange E.F. Reduced mucosal antimicrobial activity in Crohn's disease of the colon. Gut 56 (2007) 1240-1247
20. Pantosti A., Malpeli M., Wilks M., Menozzi M.G., and D'Ambrosio F. Detection of enterotoxigenic Bacteroides fragilis by PCR. J. Clin. Microbiol. 35 (1997) 2482-2486
21. Shetab R., Cohen S.H., Prindiville T., Tang Y.J., Cantrell M., Rahmani D., and Silva Jr. J. Detection of Bacteroides fragilis enterotoxin gene by PCR. J. Clin. Microbiol. 36 (1998) 1729-1732
22. Obiso Jr. R.J., Azghani A.O., and Wilkins T.D. The Bacteroides fragilis toxin fragilysin disrupts the paracellular barrier of epithelial cells, Infect. Immun 65 (1997) 1431-1439
23. Pazgier M., Prahl A., Hoover D.M., and Lubkowski J. Studies of the biological properties of human beta-defensin 1. J. Biol. Chem 282 (2007) 1819-1829
24. Harder J., Bartels J., Christophers E., and Schroder J.M. A peptide antibiotic from human skin. Nature 387 (1997) 861
25. Midorikawa K., Ouhara K., Komatsuzawa H., Kawai T., Yamada S., Fujiwara T., Yamazaki K., Sayama K., Taubman M.A., Kurihara H., Hashimoto K., and Sugai M. Staphylococcus aureus susceptibility to innate antimicrobial peptides, {beta}-defensins and CAP18, expressed by human keratinocytes. Infect. Immun 71 (2003) 3730-3739
26. Dorschner R.A., Lopez-Garcia B., Peschel A., Kraus D., Morikawa K., Nizet V., and Gallo R.L. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J 20 1 (2006) 35-42
27. Morgera F., Antcheva N., Pacor S., Quaroni L., Berti F., Vaccari L., and Tossi A. Structuring and interactions of human beta-defensins 2 and 3 with model membranes. J. Pept. Sci 14 (2008) 518-523
28. Brissette C.A., and Lukehart S.A. Mechanisms of decreased susceptibility to {beta}-defensins by Treponema denticola. Infect. Immun 75 (2007) 2307-2315
29. Kraus D., and Peschel A. Molecular mechanisms of bacterial resistance to antimicrobial peptides. Curr. Top. Microbiol. Immunol 306 (2006) 231-250
30. Edwards R., and Greenwood D. Distinctive outer membrane protein and lipopolysaccharide composition of Bacteroides fragilis strains that produce metallo-[beta]-lactamase. Anaerobe 3 (1997) 233-236
31. Krinos C.M., Coyne M.J., Weinacht K.G., Tzianabos A.O., Kasper D.L., and Comstock L.E. Extensive surface diversity of a commensal microorganism by multiple DNA inversions. Nature 414 (2001) 555-558
32. Rocha E.R., Selby T., Coleman J.P., and Smith C.J. Oxidative stress response in an anaerobe, Bacteroides fragilis: a role for catalase in protection against hydrogen peroxide. J. Bacteriol 178 (1996) 6895-6903
33. Lehrer R.I., Ganz T., Szklarek D., and Selsted M.E. Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J. Clin. Invest 81 (1988) 1829-1835
34. Swidsinski A., Weber J., Loening-Baucke V., Hale L.P., and Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J. Clin. Microbiol 43 (2005) 3380-3389
35. Wehkamp J., Salzman N.H., Porter E., Nuding S., Weichenthal M., Petras R.E., Shen B., Schaeffeler E., Schwab M., Linzmeier R., Feathers R.W., Chu H., Lima Jr. H., Fellermann K., Ganz T., Stange E.F., and Bevins C.L. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. USA 102 (2005) 18129-18134